antiviral (NAL Pharma)

N/A

Report date: 2025/06/11 10:58:58
NME

Base Information

Drug Nameantiviral (NAL Pharma)
Drug Alias NameNAL-3220NAL-3223
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNal Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNal Pharma
Inactive CompaniesN/A
Active IndicationsVaricella Zoster Virus Infection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A